NEW YORK, Sept. 17, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980….
Month: September 2024
NEW YORK, Sept. 17, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Arhaus, Inc. (“Arhaus” or the “Company”) (NASDAQ: ARHS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation…
NEW YORK, Sept. 17, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Arhaus, Inc. (“Arhaus” or the “Company”) (NASDAQ: ARHS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation…
NEW YORK, Sept. 17, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Warner Bros. Discovery, Inc. (“WBD” or the “Company”) (NASDAQ: WBD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…
NEW YORK, Sept. 17, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Warner Bros. Discovery, Inc. (“WBD” or the “Company”) (NASDAQ: WBD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…
NEW YORK, Sept. 17, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Syros Pharmaceuticals, Inc. (“Syros” or the “Company”) (NASDAQ: SYRS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…
NEW YORK, Sept. 17, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Syros Pharmaceuticals, Inc. (“Syros” or the “Company”) (NASDAQ: SYRS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…
NEW YORK, Sept. 17, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Globus Medical, Inc. (“Globus” or the “Company”) (NYSE: GMED). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…
NEW YORK, Sept. 17, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Globus Medical, Inc. (“Globus” or the “Company”) (NYSE: GMED). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…
NEW YORK, Sept. 17, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Endeavour Silver Corp. (“Endeavour” or the “Company”) (NYSE: EXK). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…